Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primatesStéphane Pillet, Brian J. Ward|Cellular and Molecular Immunology|2022Cited by 59
Efficacy and Safety of a Plant-Based Virus-Like Particle Vaccine for COVID-19 Adjuvanted with AS03Karen Hager, Ricardo Sobhie Diaz, Gretchen Heizer et al.|medRxiv|2022Cited by 7